Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2507PDF: 1936HTML: 1095 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3573PDF: 1671HTML: 4098 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5220PDF: 3023HTML: 2383 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3519PDF: 1032HTML: 4982 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2724PDF: 925HTML: 9077Efremov 1: 279Efremov 2: 250 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3117PDF: 1111HTML: 5676 -
TYROSINE KINASE INHIBITORS AND INTERFERON
3058PDF: 1531HTML: 3106Cover Letter: 273 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1939PDF: 1278HTML: 367 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4236PDF: 1654HTML: 9332Untitled: 346Untitled: 232Untitled: 218Untitled: 231Untitled: 233Untitled: 394 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3375PDF: 1448HTML: 4170 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1773HTML: 721PDF: 933 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2419PDF: 960HTML: 2034Fig 1 Rossi: 250 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3082PDF: 1366HTML: 2853Figure 1: 226 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3908PDF: 1810HTML: 2784 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
2041PDF: 912HTML: 10376Figures 1,2,3: 320 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1653PDF: 1037HTML: 272 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2448PDF: 1139HTML: 2041Characteristic of study group: 263 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1645PDF: 1355HTML: 546 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277950PDF: 1917HTML: 3916 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4812PDF: 3964HTML: 383 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2519PDF: 1409HTML: 17241Bassan Fig.1: 188Bassan Fig.2: 292Bassan Fig.4: 176Fig.3: 310 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4501PDF: 2060HTML: 5570Table 1: 300 -
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES. Hematopoietic stem cell transplatation in the elderly fo Acute Myeloid Leukemia
1934PDF: 583HTML: 372 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
2047PDF: 1265HTML: 354 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
4020PDF: 1788HTML: 11973Figures Haase: 307 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1823PDF: 1179HTML: 200 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
2513PDF: 669HTML: 391 -
POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.
1285PDF: 675Suppl. Files: 154HTML: 552 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1849PDF: 874HTML: 935jdoe, table 2 infections CML .doc: 256jdoe, table 1 infections CML .doc: 233 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
639PDF: 317HTML: 162







